[The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition]. En savoir plus sur [The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition].
Clinical implications of CTNNA1 germline mutations in asymptomatic carriers. En savoir plus sur Clinical implications of CTNNA1 germline mutations in asymptomatic carriers.